ePT--the Electronic Newsletter of Pharmaceutical Technology, Apr 7, 2011 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

ePT--the Electronic Newsletter of Pharmaceutical Technology, Apr 7, 2011
News
Pfizer’s Capsugel Fetches $2.375 Billion
By Rich Whitworth
After completing a strategic review of options for its Capsugel business, Pfizer announced on Apr. 04, 2011 that Kohlberg Kravis Roberts & Co L.P will acquire the pharmaceutical and dietary capsule company.
sanofi Completes Genzyme Acquisition
By Stephanie Sutton
sanofi-aventis has gained full control over Genzyme, bringing the much talked about acquisition deal between the two companies to a close.
J&J Reorganizes Consumer Group
By Erik Greb
Johnson & Johnson has instituted a new structure for its Consumer Group according to a Reuters report.
SOCMA Voices Concern over IST Provisions in Chemical-Site Security Measures
By Patricia Van Arnum
The Society of Chemical Manufacturers and Affiliates criticized the Secure Chemical Facilities Act, which would require chemical facilities to use inherently safer technology as part of chemical-site security measures.
Nigeria Looks to Simple Packaging Controls and International Cooperation to Curb Counterfeit Drugs
By Amy Ritter
Week of Apr. 7, 2011: Company and People Notes: ATMI Forms Distribution Pact with Finesse; AAIPharma Promotes Dean Shirazi; and More.
ATMI Forms Distribution Pact with Finesse; AAIPharma Promotes Dean Shirazi; and More.
Regulatory Roundup: New Web Search Feature on FDA.gov, Search for Product Recalls More Quickly
New Web Search Feature on FDA.gov, Search for Product Recalls More Quickly

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
35%
Breakthrough designations
12%
Protecting the supply chain
35%
Expedited reviews of drug submissions
12%
More stakeholder involvement
6%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Click here